Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
10.2%
% of IXJ's 115 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 15.1% | 8.2% |
|
JOHNSON & JOHNSON | 4.6% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 4.5% | 5.2% | 4.5% |
|
ABBVIE INC | 3.8% | 7.3% | 3.8% |
|
AMGEN INC | 2.2% | 6.1% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 6.4% |
 |
NOVO NORDISK A/S-B | 5.5% |
 |
ASTRAZENECA PLC | 3.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
 |
NOVARTIS AG | 2.9% |
|
ABBOTT LABORATORIES | 2.5% |
|
ROCHE HOLDING LTD | 2.3% |
|
DANAHER CORP | 2.3% |
|
INTUITIVE SURGICAL INC | 1.8% |
|
ELEVANCE HEALTH INC | 1.7% |
IXJ Underweight Relative to MEDX
|
ELI LILLY & CO | -6.9% |
|
NOVARTIS AG-ADR | -5.8% |
|
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
AMGEN INC | -3.9% |
|
BIOGEN IDEC INC | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
ABBVIE INC | -3.4% |
 |
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |